Completed
A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants
NCT06740474
- Conditions
- Digestive System Diseases, Hepatitis, Hepatitis D, +6 more
- Locations
-
- New Zealand Clinical Research Auckland, New Zealand